MVM
Medicxi Ventures Management Portfolio holdings
AUM
$427M
This Quarter Return
+47.69%
1 Year Return
+42.94%
3 Year Return
+262.94%
5 Year Return
+109.92%
10 Year Return
–
AUM
$449M
AUM Growth
+$449M
(+52%)
Cap. Flow
+$19.9M
Cap. Flow
% of AUM
4.44%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
Phathom Pharmaceuticals
PHAT
|
$39.3M |
Top Sells
| 1 |
Merus
MRUS
|
$19.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
1
Centessa Pharmaceuticals
CNTA
$2.25B
| $226M | 50.22% | 19,963,157 | – | – |
|
|
2
Phathom Pharmaceuticals
PHAT
$864M
| $79.3M | 17.65% | 7,464,572 +3,703,703 | +98% | +$39.3M |
|
3
NewAmsterdam Pharma
NAMS
$2.71B
| $67.9M | 15.11% | 2,869,565 | – | – |
|
|
4
Merus
MRUS
$4.98B
| $52.6M | 11.72% | 1,169,028 -430,972 | -27% | -$19.4M |
|
5
Aura Biosciences
AURA
$389M
| $23.9M | 5.31% | 3,039,892 | – | – |
|